Medicine and Dentistry
Retrospective Study
100%
Antidepressant Medication
100%
Aged Care
100%
Antidepressant
100%
Odds Ratio
81%
Tricyclic Antidepressant
36%
Selective Serotonin Reuptake Inhibitor
36%
Mood Disorder
36%
Benzodiazepine
18%
Prevalence
9%
Drug Therapy
9%
Parkinson's Disease
9%
Logistic Regression Analysis
9%
Cognitive Defect
9%
Recurrent Disease
9%
Venlafaxine
9%
Mianserin
9%
Monoamine Oxidase Inhibitor
9%
Mirtazapine
9%
Nursing and Health Professions
Aged Care
100%
Antidepressant
100%
Odds Ratio
64%
Mood Disorder
28%
Selective Serotonin Reuptake Inhibitor
28%
Tricyclic Antidepressant
28%
Benzodiazepine
14%
Prevalence
7%
Logistic Regression Analysis
7%
Drug Therapy
7%
Parkinson's Disease
7%
Cognitive Defect
7%
Recurrent Disease
7%
Medication Therapy Management
7%
Monoamine Oxidase Inhibitor
7%
Mirtazapine
7%
Mianserin
7%
Venlafaxine
7%
Pharmacology, Toxicology and Pharmaceutical Science
Retrospective Study
100%
Antidepressant
100%
Tricyclic Antidepressant
28%
Selective Serotonin Reuptake Inhibitor
28%
Mood Disorder
28%
Benzodiazepine
14%
Prevalence
7%
Pharmacotherapy
7%
Venlafaxine
7%
Parkinson's Disease
7%
Cognitive Defect
7%
Recurrent Disease
7%
Mirtazapine
7%
Monoamine Oxidase Inhibitor
7%
Mianserin
7%
Neuroscience
Antidepressant
100%
Mood Disorder
28%
Selective Serotonin Reuptake Inhibitor
28%
Tricyclic Antidepressant
28%
Benzodiazepine
14%
Parkinson's Disease
7%
Cognitive Disorders
7%
Venlafaxine
7%
Monoamine Oxidase Inhibitor
7%
Mianserin
7%
Mirtazapine
7%
Drug Therapy
7%
Psychology
Mood Disorder
100%
Benzodiazepine
50%
Regression Model
25%
Cognitive Impairment
25%
Drug Therapy
25%